Moondance Cancer Initiative (MCI) is a not-for-profit company limited by guarantee which was established in November 2019. The purpose of Moondance Cancer Initiative is to achieve Diane and Henry Engelhardt’s vision of improving cancer outcomes in Wales. Currently, these lag behind the rest of the UK and internationally. Moondance Cancer Initiative will achieve this through the judicious use of charitable funding made available by the Moondance Foundation to drive forward improvements in the provision of cancer care in Wales.
Moondance Cancer Initiative will not be a direct provider of treatment but will act as a catalyst, influencing decision-makers in the NHS and Government in Wales. Moondance Cancer Initiative will establish a think-tank modelled on the King’s Fund and the Wellcome Trust, bringing thought-leaders, external groups and expert clinicians to advise on the development of solutions across the entire cancer pathway from pre-symptom screening to treatments. It will innovate and share best practice through the funding of service transformation and research projects, through the dissemination of research and provision of education and training. It will lobby NHS Wales and Welsh Government to disrupt sub-optimum arrangements and transform clinical and commissioning pathways to improve the prevention, screening, diagnosis and treatment of cancers in Wales.
The Board of Moondance Cancer Initiative is now seeking to appoint a founding Chief Executive to bring their vision to life and improve outcomes for cancer in Wales.
For an informal discussion, please contact the Goodson Thomas team on 02921 674 422
To apply, visit www.goodsonthomas.com/vacancies, noting GT_0232_MCI in your application, and attach a copy of your CV and cover letter.
All applications will be acknowledged.
Deadline for applications: Thursday 30th April 2020